MMB-2201

MMB-2201

File:5F-AMB-PICA.svg
Systematic (IUPAC) name
(S)-methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3-methylbutanoate
Clinical data
Legal status	CA: Schedule II
Identifiers
ChemSpider	30922499
Chemical data
Formula	C20H27FN2O3
Molecular mass	362.437 g/mol
SMILES CC(C)[C@@H](C(=O)OC)NC(=O)c1cn(c2c1cccc2)CCCCCF
InChI InChI=1S/C20H27FN2O3/c1-14(2)18(20(25)26-3)22-19(24)16-13-23(12-8-4-7-11-21)17-10-6-5-9-15(16)17/h5-6,9-10,13-14,18H,4,7-8,11-12H2,1-3H3,(H,22,24)/t18-/m0/s1 Key:JFXASAFVUQVGEW-SFHVURJKSA-N

MMB-2201 (also known as 5F-MMB-PICA, 5F-AMB-PICA, and I-AMB) is an indole-3-carboxamide based synthetic cannabinoid, which has been sold as a designer drug and as an active ingredient in synthetic cannabis blends. It was first reported in Russia and Belarus in January 2014, but has since been sold in a number of other countries. It is the indole core analogue of 5F-AMB. Synthetic cannabinoid compounds with an indole-3-carboxamide or indazole-3-carboxamide core bearing a N-1-methoxycarbonyl group with attached isopropyl or t-butyl substituent, have proved to be much more dangerous than older synthetic cannabinoid compounds previously reported, and have been linked to a large number of deaths in Russia, Japan, Europe and the United States.

Legality

MMB-2201 is illegal in Russia, Belarus and Sweden.

See also

• 5F-AB-PINACA
• 5F-ADB
• MDMB-CHMICA
• MDMB-CHMINACA
• MDMB-FUBINACA